← Back to Search

Topical Agent

VTAMA® (tapinarof) Cream 1% for Psoriasis

Phase 4
Waitlist Available
Research Sponsored by Dermavant Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to week 12
Awards & highlights

Study Summary

This trial tests if a new cream can help adults with psoriasis, and assess its safety.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants who achieve an intertriginous PGA (iPGA) score of clear (0) or almost clear (1) with a ≥ 2-grade improvement
Secondary outcome measures
Time to achieve an iPGA score of 0 or 1 with a ≥ 2 grade improvement

Trial Design

1Treatment groups
Experimental Treatment
Group I: VTAMA® (tapinarof) Cream 1%Experimental Treatment1 Intervention
VTAMA® (tapinarof) Cream 1% applied topically once daily
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VTAMA® (tapinarof) Cream 1%
2023
Completed Phase 4
~40

Find a Location

Who is running the clinical trial?

Dermavant Sciences, Inc.Lead Sponsor
5 Previous Clinical Trials
1,168 Total Patients Enrolled
3 Trials studying Psoriasis
171 Patients Enrolled for Psoriasis
Victoria ButnersStudy DirectorDermavant Sciences, Inc.
3 Previous Clinical Trials
1,788 Total Patients Enrolled
3 Trials studying Psoriasis
1,788 Patients Enrolled for Psoriasis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any adverse effects associated with VTAMA® (tapinarof) Cream 1%?

"Based on the Phase 4 status of VTAMA® (tapinarof) Cream 1%, Power gave it a safety rating of 3, indicating that this treatment has been certified."

Answered by AI

Is this research initiative currently open for recruitment?

"Absolutely. Per the information held on clinicaltrials.gov, this medical trial is currently recruiting patients for participation and was initially posted on December 27th 2022 . The study requires 30 participants across 7 different sites and has been recently updated as of January 10th 2023."

Answered by AI

What is the size of the cohort currently participating in this medical trial?

"Affirmative. The clinicaltrials.gov database reveals that this medical experiment, initially launched on December 27th 2022, is currently recruiting volunteers. There are 7 trial sites looking for a total of 30 participants to join the study."

Answered by AI

Are there numerous US sites actively participating in this investigation?

"Currently, 7 sites are accepting enrolments in this medical trial. These spots span from Los Angeles to Boca Raton and Margate as well individuals residing near the other locations may join too. It is advised that you pick a site nearby for less strenuous travel requirements if joining the research endeavour."

Answered by AI

Who else is applying?

What state do they live in?
Indiana
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

To try something that could possibly help clear up my skin.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis
2023. "A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05680740.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top